nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Procarbazine—hematologic cancer	0.136	0.261	CbGbCtD
Trifluoperazine—XDH—Daunorubicin—hematologic cancer	0.0731	0.14	CbGbCtD
Trifluoperazine—ABCB1—hematologic cancer	0.0575	1	CbGaD
Trifluoperazine—XDH—Mercaptopurine—hematologic cancer	0.0566	0.108	CbGbCtD
Trifluoperazine—XDH—Cisplatin—hematologic cancer	0.0285	0.0546	CbGbCtD
Trifluoperazine—CYP1A2—Anagrelide—hematologic cancer	0.0234	0.0449	CbGbCtD
Trifluoperazine—XDH—Doxorubicin—hematologic cancer	0.0191	0.0366	CbGbCtD
Trifluoperazine—ABCB1—Lenalidomide—hematologic cancer	0.0142	0.0272	CbGbCtD
Trifluoperazine—CYP1A2—Carmustine—hematologic cancer	0.0123	0.0236	CbGbCtD
Trifluoperazine—CYP1A2—Methoxsalen—hematologic cancer	0.0105	0.02	CbGbCtD
Trifluoperazine—CYP1A2—Bortezomib—hematologic cancer	0.00996	0.0191	CbGbCtD
Trifluoperazine—CYP1A2—Daunorubicin—hematologic cancer	0.00952	0.0182	CbGbCtD
Trifluoperazine—CYP1A2—Alitretinoin—hematologic cancer	0.00933	0.0179	CbGbCtD
Trifluoperazine—CYP1A2—Thalidomide—hematologic cancer	0.00867	0.0166	CbGbCtD
Trifluoperazine—ABCB1—Daunorubicin—hematologic cancer	0.00833	0.0159	CbGbCtD
Trifluoperazine—ABCB1—Alitretinoin—hematologic cancer	0.00816	0.0156	CbGbCtD
Trifluoperazine—CYP1A2—Dacarbazine—hematologic cancer	0.00746	0.0143	CbGbCtD
Trifluoperazine—CYP1A2—Imatinib—hematologic cancer	0.00729	0.014	CbGbCtD
Trifluoperazine—ABCB1—Imatinib—hematologic cancer	0.00638	0.0122	CbGbCtD
Trifluoperazine—CYP1A2—Dasatinib—hematologic cancer	0.00586	0.0112	CbGbCtD
Trifluoperazine—ABCB1—Nilotinib—hematologic cancer	0.0058	0.0111	CbGbCtD
Trifluoperazine—ABCB1—Vinorelbine—hematologic cancer	0.00575	0.011	CbGbCtD
Trifluoperazine—ABCB1—Dasatinib—hematologic cancer	0.00512	0.00981	CbGbCtD
Trifluoperazine—ABCB1—Mitoxantrone—hematologic cancer	0.00506	0.00969	CbGbCtD
Trifluoperazine—ABCB1—Betamethasone—hematologic cancer	0.00451	0.00863	CbGbCtD
Trifluoperazine—ABCB1—Gemcitabine—hematologic cancer	0.00447	0.00856	CbGbCtD
Trifluoperazine—ABCB1—Prednisolone—hematologic cancer	0.00445	0.00852	CbGbCtD
Trifluoperazine—ABCB1—Prednisone—hematologic cancer	0.0042	0.00804	CbGbCtD
Trifluoperazine—ABCB1—Irinotecan—hematologic cancer	0.00398	0.00763	CbGbCtD
Trifluoperazine—CYP1A2—Etoposide—hematologic cancer	0.00365	0.00699	CbGbCtD
Trifluoperazine—ABCB1—Vinblastine—hematologic cancer	0.00354	0.00678	CbGbCtD
Trifluoperazine—ABCB1—Vincristine—hematologic cancer	0.00348	0.00667	CbGbCtD
Trifluoperazine—ABCB1—Cisplatin—hematologic cancer	0.00325	0.00622	CbGbCtD
Trifluoperazine—ABCB1—Etoposide—hematologic cancer	0.00319	0.00611	CbGbCtD
Trifluoperazine—S100A4—hematopoietic system—hematologic cancer	0.003	0.0531	CbGeAlD
Trifluoperazine—UGT1A4—hematopoietic system—hematologic cancer	0.00264	0.0467	CbGeAlD
Trifluoperazine—ABCB1—Dexamethasone—hematologic cancer	0.00262	0.00502	CbGbCtD
Trifluoperazine—TNNC1—hematopoietic system—hematologic cancer	0.00253	0.0447	CbGeAlD
Trifluoperazine—EBPL—lung—hematologic cancer	0.00221	0.0391	CbGeAlD
Trifluoperazine—ABCB1—Doxorubicin—hematologic cancer	0.00218	0.00417	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—hematologic cancer	0.00211	0.00404	CbGbCtD
Trifluoperazine—EBPL—testis—hematologic cancer	0.00208	0.0369	CbGeAlD
Trifluoperazine—S100A4—blood—hematologic cancer	0.00199	0.0352	CbGeAlD
Trifluoperazine—S100A4—bone marrow—hematologic cancer	0.00192	0.0341	CbGeAlD
Trifluoperazine—CALY—testis—hematologic cancer	0.00191	0.0337	CbGeAlD
Trifluoperazine—UGT1A4—blood—hematologic cancer	0.00175	0.0309	CbGeAlD
Trifluoperazine—S100A4—lung—hematologic cancer	0.00174	0.0309	CbGeAlD
Trifluoperazine—TNNC1—blood—hematologic cancer	0.00167	0.0296	CbGeAlD
Trifluoperazine—S100A4—testis—hematologic cancer	0.00165	0.0291	CbGeAlD
Trifluoperazine—EBPL—lymph node—hematologic cancer	0.00151	0.0267	CbGeAlD
Trifluoperazine—TNNC1—lung—hematologic cancer	0.00147	0.026	CbGeAlD
Trifluoperazine—TNNC1—testis—hematologic cancer	0.00139	0.0245	CbGeAlD
Trifluoperazine—CALY—lymph node—hematologic cancer	0.00138	0.0245	CbGeAlD
Trifluoperazine—S100A4—lymph node—hematologic cancer	0.00119	0.0211	CbGeAlD
Trifluoperazine—S100A4—Isotretinoin—Alitretinoin—hematologic cancer	0.00118	0.301	CbGdCrCtD
Trifluoperazine—S100A4—Tretinoin—Alitretinoin—hematologic cancer	0.00118	0.301	CbGdCrCtD
Trifluoperazine—TNNC1—lymph node—hematologic cancer	0.001	0.0178	CbGeAlD
Trifluoperazine—HTR1A—hematopoietic system—hematologic cancer	0.000879	0.0156	CbGeAlD
Trifluoperazine—CALM2—hematopoietic system—hematologic cancer	0.000864	0.0153	CbGeAlD
Trifluoperazine—CALM1—hematopoietic system—hematologic cancer	0.00086	0.0152	CbGeAlD
Trifluoperazine—ADRA1A—hematopoietic system—hematologic cancer	0.000811	0.0143	CbGeAlD
Trifluoperazine—CALM3—blood—hematologic cancer	0.000729	0.0129	CbGeAlD
Trifluoperazine—CALM3—bone marrow—hematologic cancer	0.000706	0.0125	CbGeAlD
Trifluoperazine—CYP1A2—hematopoietic system—hematologic cancer	0.00067	0.0119	CbGeAlD
Trifluoperazine—CALM2—gonad—hematologic cancer	0.000657	0.0116	CbGeAlD
Trifluoperazine—CALM1—gonad—hematologic cancer	0.000654	0.0116	CbGeAlD
Trifluoperazine—SIGMAR1—blood—hematologic cancer	0.000652	0.0115	CbGeAlD
Trifluoperazine—CALM3—lung—hematologic cancer	0.000639	0.0113	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—hematologic cancer	0.000631	0.0112	CbGeAlD
Trifluoperazine—HRH1—hematopoietic system—hematologic cancer	0.000628	0.0111	CbGeAlD
Trifluoperazine—CALM3—testis—hematologic cancer	0.000603	0.0107	CbGeAlD
Trifluoperazine—CALM2—blood—hematologic cancer	0.000573	0.0101	CbGeAlD
Trifluoperazine—SIGMAR1—lung—hematologic cancer	0.000571	0.0101	CbGeAlD
Trifluoperazine—CALM1—blood—hematologic cancer	0.00057	0.0101	CbGeAlD
Trifluoperazine—CALM2—bone marrow—hematologic cancer	0.000554	0.00981	CbGeAlD
Trifluoperazine—CALM1—bone marrow—hematologic cancer	0.000552	0.00976	CbGeAlD
Trifluoperazine—SIGMAR1—testis—hematologic cancer	0.000539	0.00954	CbGeAlD
Trifluoperazine—ADRA1A—blood—hematologic cancer	0.000537	0.00951	CbGeAlD
Trifluoperazine—HTR2A—hematopoietic system—hematologic cancer	0.000524	0.00928	CbGeAlD
Trifluoperazine—CALM2—lung—hematologic cancer	0.000502	0.00889	CbGeAlD
Trifluoperazine—CALM1—lung—hematologic cancer	0.0005	0.00884	CbGeAlD
Trifluoperazine—CALM2—testis—hematologic cancer	0.000474	0.00838	CbGeAlD
Trifluoperazine—CALM1—testis—hematologic cancer	0.000471	0.00834	CbGeAlD
Trifluoperazine—DRD2—lung—hematologic cancer	0.000462	0.00817	CbGeAlD
Trifluoperazine—CYP1A2—blood—hematologic cancer	0.000444	0.00786	CbGeAlD
Trifluoperazine—CALM3—lymph node—hematologic cancer	0.000437	0.00774	CbGeAlD
Trifluoperazine—DRD2—testis—hematologic cancer	0.000435	0.00771	CbGeAlD
Trifluoperazine—HTR2A—gonad—hematologic cancer	0.000399	0.00705	CbGeAlD
Trifluoperazine—SIGMAR1—lymph node—hematologic cancer	0.000391	0.00692	CbGeAlD
Trifluoperazine—CYP1A2—lung—hematologic cancer	0.000389	0.00689	CbGeAlD
Trifluoperazine—HRH1—lung—hematologic cancer	0.000364	0.00645	CbGeAlD
Trifluoperazine—HTR2A—blood—hematologic cancer	0.000347	0.00615	CbGeAlD
Trifluoperazine—HRH1—testis—hematologic cancer	0.000344	0.00609	CbGeAlD
Trifluoperazine—ABCB1—hematopoietic system—hematologic cancer	0.000343	0.00608	CbGeAlD
Trifluoperazine—CALM2—lymph node—hematologic cancer	0.000343	0.00608	CbGeAlD
Trifluoperazine—CALM1—lymph node—hematologic cancer	0.000342	0.00605	CbGeAlD
Trifluoperazine—Quetiapine—H1F0—hematologic cancer	0.000323	0.141	CrCbGaD
Trifluoperazine—HTR2A—lung—hematologic cancer	0.000304	0.00539	CbGeAlD
Trifluoperazine—HTR2A—testis—hematologic cancer	0.000287	0.00508	CbGeAlD
Trifluoperazine—Clozapine—H1F0—hematologic cancer	0.000278	0.121	CrCbGaD
Trifluoperazine—ABCB1—gonad—hematologic cancer	0.000261	0.00462	CbGeAlD
Trifluoperazine—HRH1—lymph node—hematologic cancer	0.000249	0.00441	CbGeAlD
Trifluoperazine—ABCB1—blood—hematologic cancer	0.000228	0.00403	CbGeAlD
Trifluoperazine—ABCB1—bone marrow—hematologic cancer	0.00022	0.0039	CbGeAlD
Trifluoperazine—ABCB1—lung—hematologic cancer	0.000199	0.00353	CbGeAlD
Trifluoperazine—ABCB1—testis—hematologic cancer	0.000188	0.00333	CbGeAlD
Trifluoperazine—Acepromazine—SLC22A1—hematologic cancer	0.000178	0.0777	CrCbGaD
Trifluoperazine—Thioproperazine—SLC22A1—hematologic cancer	0.000174	0.076	CrCbGaD
Trifluoperazine—Pipotiazine—SLC22A1—hematologic cancer	0.000171	0.0747	CrCbGaD
Trifluoperazine—Thiothixene—SLC22A1—hematologic cancer	0.000171	0.0747	CrCbGaD
Trifluoperazine—S100A4—Desoximetasone—Dexamethasone—hematologic cancer	0.000162	0.0411	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Betamethasone—hematologic cancer	0.000162	0.0411	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Triamcinolone—hematologic cancer	0.000158	0.0401	CbGdCrCtD
Trifluoperazine—EBP—Azacitidine—Pentostatin—hematologic cancer	0.000151	0.0384	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisone—hematologic cancer	0.00015	0.0381	CbGdCrCtD
Trifluoperazine—Clomipramine—GSTP1—hematologic cancer	0.000146	0.0639	CrCbGaD
Trifluoperazine—S100A4—Desoximetasone—Prednisolone—hematologic cancer	0.000146	0.0372	CbGdCrCtD
Trifluoperazine—ABCB1—lymph node—hematologic cancer	0.000136	0.00241	CbGeAlD
Trifluoperazine—EBP—Azacitidine—Clofarabine—hematologic cancer	0.000135	0.0342	CbGdCrCtD
Trifluoperazine—EBP—Azacitidine—Nelarabine—hematologic cancer	0.000127	0.0322	CbGdCrCtD
Trifluoperazine—Flupentixol—ABCB1—hematologic cancer	0.000103	0.0449	CrCbGaD
Trifluoperazine—EBP—Azacitidine—Fludarabine—hematologic cancer	9.88e-05	0.0251	CbGdCrCtD
Trifluoperazine—EBP—Azacitidine—Cytarabine—hematologic cancer	9.33e-05	0.0237	CbGdCrCtD
Trifluoperazine—EBP—Azacitidine—Gemcitabine—hematologic cancer	9.33e-05	0.0237	CbGdCrCtD
Trifluoperazine—Chlorpromazine—SLC22A1—hematologic cancer	9.29e-05	0.0405	CrCbGaD
Trifluoperazine—EBP—Azacitidine—Cladribine—hematologic cancer	9.09e-05	0.0231	CbGdCrCtD
Trifluoperazine—Nefazodone—ABCB1—hematologic cancer	5.75e-05	0.0251	CrCbGaD
Trifluoperazine—Triflupromazine—ABCB1—hematologic cancer	5.6e-05	0.0244	CrCbGaD
Trifluoperazine—Acepromazine—ALB—hematologic cancer	5.43e-05	0.0237	CrCbGaD
Trifluoperazine—Trazodone—ABCB1—hematologic cancer	5.32e-05	0.0232	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—hematologic cancer	5.31e-05	0.0231	CrCbGaD
Trifluoperazine—Thiothixene—ALB—hematologic cancer	5.22e-05	0.0228	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—hematologic cancer	5.22e-05	0.0228	CrCbGaD
Trifluoperazine—Asthenia—Ifosfamide—hematologic cancer	5.14e-05	0.000253	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Triamcinolone—hematologic cancer	5.13e-05	0.000252	CcSEcCtD
Trifluoperazine—Pruritus—Alitretinoin—hematologic cancer	5.12e-05	0.000252	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—hematologic cancer	5.11e-05	0.000251	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Epirubicin—hematologic cancer	5.09e-05	0.00025	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—hematologic cancer	5.07e-05	0.000249	CcSEcCtD
Trifluoperazine—Pruritus—Ifosfamide—hematologic cancer	5.07e-05	0.000249	CcSEcCtD
Trifluoperazine—Insomnia—Prednisolone—hematologic cancer	5.04e-05	0.000248	CcSEcCtD
Trifluoperazine—Dyspnoea—Etoposide—hematologic cancer	5.04e-05	0.000248	CcSEcCtD
Trifluoperazine—Dizziness—Thalidomide—hematologic cancer	5.03e-05	0.000248	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—hematologic cancer	5.03e-05	0.000247	CcSEcCtD
Trifluoperazine—Somnolence—Etoposide—hematologic cancer	5.03e-05	0.000247	CcSEcCtD
Trifluoperazine—Nausea—Bortezomib—hematologic cancer	5.01e-05	0.000247	CcSEcCtD
Trifluoperazine—Hypersensitivity—Mitoxantrone—hematologic cancer	5.01e-05	0.000246	CcSEcCtD
Trifluoperazine—Hypersensitivity—Irinotecan—hematologic cancer	5.01e-05	0.000246	CcSEcCtD
Trifluoperazine—Asthenia—Vincristine—hematologic cancer	5.01e-05	0.000246	CcSEcCtD
Trifluoperazine—Nausea—Bleomycin—hematologic cancer	4.98e-05	0.000245	CcSEcCtD
Trifluoperazine—Drowsiness—Epirubicin—hematologic cancer	4.97e-05	0.000244	CcSEcCtD
Trifluoperazine—Erythema—Prednisone—hematologic cancer	4.97e-05	0.000244	CcSEcCtD
Trifluoperazine—Rash—Thiotepa—hematologic cancer	4.96e-05	0.000244	CcSEcCtD
Trifluoperazine—Dermatitis—Thiotepa—hematologic cancer	4.96e-05	0.000244	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—hematologic cancer	4.96e-05	0.000244	CcSEcCtD
Trifluoperazine—Convulsion—Dexamethasone—hematologic cancer	4.94e-05	0.000243	CcSEcCtD
Trifluoperazine—Convulsion—Betamethasone—hematologic cancer	4.94e-05	0.000243	CcSEcCtD
Trifluoperazine—Headache—Thiotepa—hematologic cancer	4.93e-05	0.000242	CcSEcCtD
Trifluoperazine—Decreased appetite—Etoposide—hematologic cancer	4.92e-05	0.000242	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—hematologic cancer	4.9e-05	0.000241	CcSEcCtD
Trifluoperazine—Nausea—Vinorelbine—hematologic cancer	4.9e-05	0.000241	CcSEcCtD
Trifluoperazine—Body temperature increased—Cisplatin—hematologic cancer	4.88e-05	0.00024	CcSEcCtD
Trifluoperazine—Asthenia—Irinotecan—hematologic cancer	4.88e-05	0.00024	CcSEcCtD
Trifluoperazine—Asthenia—Mitoxantrone—hematologic cancer	4.88e-05	0.00024	CcSEcCtD
Trifluoperazine—Fatigue—Etoposide—hematologic cancer	4.87e-05	0.00024	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—hematologic cancer	4.84e-05	0.000238	CcSEcCtD
Trifluoperazine—Dizziness—Carmustine—hematologic cancer	4.84e-05	0.000238	CcSEcCtD
Trifluoperazine—Constipation—Etoposide—hematologic cancer	4.84e-05	0.000238	CcSEcCtD
Trifluoperazine—Rash—Thalidomide—hematologic cancer	4.8e-05	0.000236	CcSEcCtD
Trifluoperazine—Dermatitis—Thalidomide—hematologic cancer	4.8e-05	0.000236	CcSEcCtD
Trifluoperazine—Dizziness—Alitretinoin—hematologic cancer	4.79e-05	0.000236	CcSEcCtD
Trifluoperazine—Headache—Thalidomide—hematologic cancer	4.77e-05	0.000235	CcSEcCtD
Trifluoperazine—Asthenia—Gemcitabine—hematologic cancer	4.75e-05	0.000234	CcSEcCtD
Trifluoperazine—Dizziness—Ifosfamide—hematologic cancer	4.73e-05	0.000233	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	4.71e-05	0.000231	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—hematologic cancer	4.69e-05	0.000231	CcSEcCtD
Trifluoperazine—Pruritus—Gemcitabine—hematologic cancer	4.68e-05	0.00023	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisone—hematologic cancer	4.68e-05	0.00023	CcSEcCtD
Trifluoperazine—Nausea—Thiotepa—hematologic cancer	4.68e-05	0.00023	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Dexamethasone—hematologic cancer	4.65e-05	0.000229	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Betamethasone—hematologic cancer	4.65e-05	0.000229	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Doxorubicin—hematologic cancer	4.65e-05	0.000229	CcSEcCtD
Trifluoperazine—Insomnia—Triamcinolone—hematologic cancer	4.64e-05	0.000228	CcSEcCtD
Trifluoperazine—Agranulocytosis—Epirubicin—hematologic cancer	4.64e-05	0.000228	CcSEcCtD
Trifluoperazine—Dizziness—Vincristine—hematologic cancer	4.62e-05	0.000227	CcSEcCtD
Trifluoperazine—Rash—Carmustine—hematologic cancer	4.61e-05	0.000227	CcSEcCtD
Trifluoperazine—Dermatitis—Carmustine—hematologic cancer	4.61e-05	0.000227	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—hematologic cancer	4.6e-05	0.000226	CcSEcCtD
Trifluoperazine—Headache—Carmustine—hematologic cancer	4.58e-05	0.000225	CcSEcCtD
Trifluoperazine—Dyspnoea—Triamcinolone—hematologic cancer	4.57e-05	0.000225	CcSEcCtD
Trifluoperazine—Rash—Alitretinoin—hematologic cancer	4.57e-05	0.000225	CcSEcCtD
Trifluoperazine—Agitation—Prednisone—hematologic cancer	4.56e-05	0.000224	CcSEcCtD
Trifluoperazine—Dermatitis—Alitretinoin—hematologic cancer	4.56e-05	0.000224	CcSEcCtD
Trifluoperazine—Hypersensitivity—Cisplatin—hematologic cancer	4.55e-05	0.000224	CcSEcCtD
Trifluoperazine—Headache—Alitretinoin—hematologic cancer	4.54e-05	0.000223	CcSEcCtD
Trifluoperazine—Angioedema—Prednisone—hematologic cancer	4.54e-05	0.000223	CcSEcCtD
Trifluoperazine—Nausea—Thalidomide—hematologic cancer	4.52e-05	0.000222	CcSEcCtD
Trifluoperazine—Rash—Ifosfamide—hematologic cancer	4.51e-05	0.000222	CcSEcCtD
Trifluoperazine—Dermatitis—Ifosfamide—hematologic cancer	4.51e-05	0.000222	CcSEcCtD
Trifluoperazine—Dizziness—Irinotecan—hematologic cancer	4.5e-05	0.000221	CcSEcCtD
Trifluoperazine—Urticaria—Etoposide—hematologic cancer	4.49e-05	0.000221	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—hematologic cancer	4.48e-05	0.00022	CcSEcCtD
Trifluoperazine—Body temperature increased—Etoposide—hematologic cancer	4.47e-05	0.00022	CcSEcCtD
Trifluoperazine—Anorexia—Betamethasone—hematologic cancer	4.44e-05	0.000218	CcSEcCtD
Trifluoperazine—Anorexia—Dexamethasone—hematologic cancer	4.44e-05	0.000218	CcSEcCtD
Trifluoperazine—Urticaria—Prednisolone—hematologic cancer	4.43e-05	0.000218	CcSEcCtD
Trifluoperazine—Asthenia—Cisplatin—hematologic cancer	4.43e-05	0.000218	CcSEcCtD
Trifluoperazine—Fatigue—Triamcinolone—hematologic cancer	4.42e-05	0.000217	CcSEcCtD
Trifluoperazine—Rash—Vincristine—hematologic cancer	4.4e-05	0.000216	CcSEcCtD
Trifluoperazine—Dermatitis—Vincristine—hematologic cancer	4.4e-05	0.000216	CcSEcCtD
Trifluoperazine—Oedema peripheral—Epirubicin—hematologic cancer	4.39e-05	0.000216	CcSEcCtD
Trifluoperazine—Headache—Vincristine—hematologic cancer	4.37e-05	0.000215	CcSEcCtD
Trifluoperazine—Hypotension—Betamethasone—hematologic cancer	4.35e-05	0.000214	CcSEcCtD
Trifluoperazine—Hypotension—Dexamethasone—hematologic cancer	4.35e-05	0.000214	CcSEcCtD
Trifluoperazine—Nausea—Carmustine—hematologic cancer	4.34e-05	0.000214	CcSEcCtD
Trifluoperazine—Fluphenazine—ABCB1—hematologic cancer	4.31e-05	0.0188	CrCbGaD
Trifluoperazine—Nausea—Alitretinoin—hematologic cancer	4.3e-05	0.000212	CcSEcCtD
Trifluoperazine—Convulsion—Prednisone—hematologic cancer	4.3e-05	0.000212	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—hematologic cancer	4.29e-05	0.000211	CcSEcCtD
Trifluoperazine—Rash—Irinotecan—hematologic cancer	4.29e-05	0.000211	CcSEcCtD
Trifluoperazine—Rash—Mitoxantrone—hematologic cancer	4.29e-05	0.000211	CcSEcCtD
Trifluoperazine—Dermatitis—Mitoxantrone—hematologic cancer	4.28e-05	0.000211	CcSEcCtD
Trifluoperazine—Dermatitis—Irinotecan—hematologic cancer	4.28e-05	0.000211	CcSEcCtD
Trifluoperazine—Headache—Mitoxantrone—hematologic cancer	4.26e-05	0.000209	CcSEcCtD
Trifluoperazine—Headache—Irinotecan—hematologic cancer	4.26e-05	0.000209	CcSEcCtD
Trifluoperazine—Nausea—Ifosfamide—hematologic cancer	4.25e-05	0.000209	CcSEcCtD
Trifluoperazine—Insomnia—Betamethasone—hematologic cancer	4.21e-05	0.000207	CcSEcCtD
Trifluoperazine—Insomnia—Dexamethasone—hematologic cancer	4.21e-05	0.000207	CcSEcCtD
Trifluoperazine—Rash—Gemcitabine—hematologic cancer	4.18e-05	0.000205	CcSEcCtD
Trifluoperazine—Dermatitis—Gemcitabine—hematologic cancer	4.17e-05	0.000205	CcSEcCtD
Trifluoperazine—Hypersensitivity—Etoposide—hematologic cancer	4.17e-05	0.000205	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—hematologic cancer	4.15e-05	0.000204	CcSEcCtD
Trifluoperazine—Headache—Gemcitabine—hematologic cancer	4.15e-05	0.000204	CcSEcCtD
Trifluoperazine—Nausea—Vincristine—hematologic cancer	4.15e-05	0.000204	CcSEcCtD
Trifluoperazine—Clomipramine—ALB—hematologic cancer	4.13e-05	0.018	CrCbGaD
Trifluoperazine—Hypersensitivity—Prednisolone—hematologic cancer	4.11e-05	0.000202	CcSEcCtD
Trifluoperazine—Urticaria—Triamcinolone—hematologic cancer	4.07e-05	0.0002	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—hematologic cancer	4.07e-05	0.0002	CcSEcCtD
Trifluoperazine—Asthenia—Etoposide—hematologic cancer	4.06e-05	0.000199	CcSEcCtD
Trifluoperazine—Body temperature increased—Triamcinolone—hematologic cancer	4.05e-05	0.000199	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisone—hematologic cancer	4.05e-05	0.000199	CcSEcCtD
Trifluoperazine—Decreased appetite—Dexamethasone—hematologic cancer	4.05e-05	0.000199	CcSEcCtD
Trifluoperazine—Decreased appetite—Betamethasone—hematologic cancer	4.05e-05	0.000199	CcSEcCtD
Trifluoperazine—Nausea—Mitoxantrone—hematologic cancer	4.04e-05	0.000199	CcSEcCtD
Trifluoperazine—Nausea—Irinotecan—hematologic cancer	4.04e-05	0.000199	CcSEcCtD
Trifluoperazine—Fatigue—Betamethasone—hematologic cancer	4.01e-05	0.000197	CcSEcCtD
Trifluoperazine—Fatigue—Dexamethasone—hematologic cancer	4.01e-05	0.000197	CcSEcCtD
Trifluoperazine—Pruritus—Etoposide—hematologic cancer	4e-05	0.000197	CcSEcCtD
Trifluoperazine—Clomipramine—ABCB1—hematologic cancer	3.94e-05	0.0172	CrCbGaD
Trifluoperazine—Skin disorder—Prednisone—hematologic cancer	3.94e-05	0.000194	CcSEcCtD
Trifluoperazine—Nausea—Gemcitabine—hematologic cancer	3.93e-05	0.000193	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—hematologic cancer	3.91e-05	0.000192	CcSEcCtD
Trifluoperazine—Rash—Cisplatin—hematologic cancer	3.89e-05	0.000191	CcSEcCtD
Trifluoperazine—Dermatitis—Cisplatin—hematologic cancer	3.89e-05	0.000191	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—hematologic cancer	3.88e-05	0.000191	CcSEcCtD
Trifluoperazine—Anorexia—Prednisone—hematologic cancer	3.86e-05	0.00019	CcSEcCtD
Trifluoperazine—Hypersensitivity—Triamcinolone—hematologic cancer	3.78e-05	0.000186	CcSEcCtD
Trifluoperazine—Nervousness—Epirubicin—hematologic cancer	3.77e-05	0.000185	CcSEcCtD
Trifluoperazine—Dizziness—Etoposide—hematologic cancer	3.74e-05	0.000184	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—hematologic cancer	3.73e-05	0.000184	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—hematologic cancer	3.71e-05	0.000183	CcSEcCtD
Trifluoperazine—Urticaria—Betamethasone—hematologic cancer	3.7e-05	0.000182	CcSEcCtD
Trifluoperazine—Urticaria—Dexamethasone—hematologic cancer	3.7e-05	0.000182	CcSEcCtD
Trifluoperazine—Dizziness—Prednisolone—hematologic cancer	3.69e-05	0.000181	CcSEcCtD
Trifluoperazine—Asthenia—Triamcinolone—hematologic cancer	3.68e-05	0.000181	CcSEcCtD
Trifluoperazine—Body temperature increased—Betamethasone—hematologic cancer	3.68e-05	0.000181	CcSEcCtD
Trifluoperazine—Body temperature increased—Dexamethasone—hematologic cancer	3.68e-05	0.000181	CcSEcCtD
Trifluoperazine—Nausea—Cisplatin—hematologic cancer	3.67e-05	0.00018	CcSEcCtD
Trifluoperazine—Insomnia—Prednisone—hematologic cancer	3.67e-05	0.00018	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—hematologic cancer	3.66e-05	0.00018	CcSEcCtD
Trifluoperazine—Pruritus—Triamcinolone—hematologic cancer	3.63e-05	0.000178	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—hematologic cancer	3.62e-05	0.000178	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—hematologic cancer	3.6e-05	0.000177	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—hematologic cancer	3.59e-05	0.000177	CcSEcCtD
Trifluoperazine—Agitation—Epirubicin—hematologic cancer	3.57e-05	0.000175	CcSEcCtD
Trifluoperazine—Rash—Etoposide—hematologic cancer	3.57e-05	0.000175	CcSEcCtD
Trifluoperazine—Dermatitis—Etoposide—hematologic cancer	3.56e-05	0.000175	CcSEcCtD
Trifluoperazine—Headache—Etoposide—hematologic cancer	3.54e-05	0.000174	CcSEcCtD
Trifluoperazine—Decreased appetite—Prednisone—hematologic cancer	3.52e-05	0.000173	CcSEcCtD
Trifluoperazine—Rash—Prednisolone—hematologic cancer	3.52e-05	0.000173	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisolone—hematologic cancer	3.51e-05	0.000173	CcSEcCtD
Trifluoperazine—Fatigue—Prednisone—hematologic cancer	3.49e-05	0.000172	CcSEcCtD
Trifluoperazine—Headache—Prednisolone—hematologic cancer	3.49e-05	0.000172	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—hematologic cancer	3.49e-05	0.000172	CcSEcCtD
Trifluoperazine—Promethazine—ABCB1—hematologic cancer	3.49e-05	0.0152	CrCbGaD
Trifluoperazine—Leukopenia—Epirubicin—hematologic cancer	3.48e-05	0.000171	CcSEcCtD
Trifluoperazine—Constipation—Prednisone—hematologic cancer	3.47e-05	0.00017	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—hematologic cancer	3.45e-05	0.00017	CcSEcCtD
Trifluoperazine—Dizziness—Triamcinolone—hematologic cancer	3.39e-05	0.000167	CcSEcCtD
Trifluoperazine—Cough—Epirubicin—hematologic cancer	3.39e-05	0.000167	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—hematologic cancer	3.39e-05	0.000167	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—hematologic cancer	3.39e-05	0.000167	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—hematologic cancer	3.36e-05	0.000165	CcSEcCtD
Trifluoperazine—Nausea—Etoposide—hematologic cancer	3.36e-05	0.000165	CcSEcCtD
Trifluoperazine—Asthenia—Betamethasone—hematologic cancer	3.34e-05	0.000164	CcSEcCtD
Trifluoperazine—Asthenia—Dexamethasone—hematologic cancer	3.34e-05	0.000164	CcSEcCtD
Trifluoperazine—Quetiapine—ABCB1—hematologic cancer	3.34e-05	0.0146	CrCbGaD
Trifluoperazine—Nausea—Prednisolone—hematologic cancer	3.31e-05	0.000163	CcSEcCtD
Trifluoperazine—Agitation—Doxorubicin—hematologic cancer	3.3e-05	0.000162	CcSEcCtD
Trifluoperazine—Pruritus—Betamethasone—hematologic cancer	3.29e-05	0.000162	CcSEcCtD
Trifluoperazine—Pruritus—Dexamethasone—hematologic cancer	3.29e-05	0.000162	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—hematologic cancer	3.29e-05	0.000162	CcSEcCtD
Trifluoperazine—Rash—Triamcinolone—hematologic cancer	3.23e-05	0.000159	CcSEcCtD
Trifluoperazine—Dry mouth—Epirubicin—hematologic cancer	3.23e-05	0.000159	CcSEcCtD
Trifluoperazine—Dermatitis—Triamcinolone—hematologic cancer	3.23e-05	0.000159	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—hematologic cancer	3.23e-05	0.000159	CcSEcCtD
Trifluoperazine—Urticaria—Prednisone—hematologic cancer	3.22e-05	0.000158	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—hematologic cancer	3.22e-05	0.000158	CcSEcCtD
Trifluoperazine—Headache—Triamcinolone—hematologic cancer	3.21e-05	0.000158	CcSEcCtD
Trifluoperazine—Body temperature increased—Prednisone—hematologic cancer	3.2e-05	0.000158	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Epirubicin—hematologic cancer	3.17e-05	0.000156	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—hematologic cancer	3.16e-05	0.000156	CcSEcCtD
Trifluoperazine—Cough—Doxorubicin—hematologic cancer	3.14e-05	0.000154	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—hematologic cancer	3.11e-05	0.000153	CcSEcCtD
Trifluoperazine—Skin disorder—Epirubicin—hematologic cancer	3.08e-05	0.000151	CcSEcCtD
Trifluoperazine—Dizziness—Betamethasone—hematologic cancer	3.08e-05	0.000151	CcSEcCtD
Trifluoperazine—Dizziness—Dexamethasone—hematologic cancer	3.08e-05	0.000151	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—hematologic cancer	3.06e-05	0.000151	CcSEcCtD
Trifluoperazine—Nausea—Triamcinolone—hematologic cancer	3.05e-05	0.00015	CcSEcCtD
Trifluoperazine—Anorexia—Epirubicin—hematologic cancer	3.02e-05	0.000149	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—hematologic cancer	3.02e-05	0.000148	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—hematologic cancer	3.01e-05	0.000148	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—hematologic cancer	2.99e-05	0.000147	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisone—hematologic cancer	2.99e-05	0.000147	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—hematologic cancer	2.96e-05	0.000146	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—hematologic cancer	2.94e-05	0.000145	CcSEcCtD
Trifluoperazine—Rash—Betamethasone—hematologic cancer	2.93e-05	0.000144	CcSEcCtD
Trifluoperazine—Rash—Dexamethasone—hematologic cancer	2.93e-05	0.000144	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.93e-05	0.000144	CcSEcCtD
Trifluoperazine—Dermatitis—Betamethasone—hematologic cancer	2.93e-05	0.000144	CcSEcCtD
Trifluoperazine—Dermatitis—Dexamethasone—hematologic cancer	2.93e-05	0.000144	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—hematologic cancer	2.92e-05	0.000144	CcSEcCtD
Trifluoperazine—Headache—Betamethasone—hematologic cancer	2.92e-05	0.000143	CcSEcCtD
Trifluoperazine—Headache—Dexamethasone—hematologic cancer	2.92e-05	0.000143	CcSEcCtD
Trifluoperazine—Asthenia—Prednisone—hematologic cancer	2.91e-05	0.000143	CcSEcCtD
Trifluoperazine—Clozapine—ABCB1—hematologic cancer	2.87e-05	0.0125	CrCbGaD
Trifluoperazine—Pruritus—Prednisone—hematologic cancer	2.87e-05	0.000141	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—hematologic cancer	2.87e-05	0.000141	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—hematologic cancer	2.85e-05	0.00014	CcSEcCtD
Trifluoperazine—Chlorpromazine—ALB—hematologic cancer	2.83e-05	0.0123	CrCbGaD
Trifluoperazine—Dyspnoea—Epirubicin—hematologic cancer	2.83e-05	0.000139	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—hematologic cancer	2.82e-05	0.000139	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—hematologic cancer	2.8e-05	0.000137	CcSEcCtD
Trifluoperazine—Nausea—Betamethasone—hematologic cancer	2.76e-05	0.000136	CcSEcCtD
Trifluoperazine—Nausea—Dexamethasone—hematologic cancer	2.76e-05	0.000136	CcSEcCtD
Trifluoperazine—Decreased appetite—Epirubicin—hematologic cancer	2.76e-05	0.000135	CcSEcCtD
Trifluoperazine—Hypotension—Doxorubicin—hematologic cancer	2.74e-05	0.000135	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—hematologic cancer	2.73e-05	0.000134	CcSEcCtD
Trifluoperazine—Constipation—Epirubicin—hematologic cancer	2.71e-05	0.000133	CcSEcCtD
Trifluoperazine—Chlorpromazine—ABCB1—hematologic cancer	2.7e-05	0.0118	CrCbGaD
Trifluoperazine—Urticaria—Methotrexate—hematologic cancer	2.69e-05	0.000132	CcSEcCtD
Trifluoperazine—Dizziness—Prednisone—hematologic cancer	2.68e-05	0.000132	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—hematologic cancer	2.68e-05	0.000132	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—hematologic cancer	2.65e-05	0.00013	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—hematologic cancer	2.61e-05	0.000129	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—hematologic cancer	2.61e-05	0.000128	CcSEcCtD
Trifluoperazine—Rash—Prednisone—hematologic cancer	2.56e-05	0.000126	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisone—hematologic cancer	2.55e-05	0.000126	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—hematologic cancer	2.55e-05	0.000125	CcSEcCtD
Trifluoperazine—Headache—Prednisone—hematologic cancer	2.54e-05	0.000125	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—hematologic cancer	2.53e-05	0.000124	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—hematologic cancer	2.52e-05	0.000124	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—hematologic cancer	2.51e-05	0.000123	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—hematologic cancer	2.51e-05	0.000123	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—hematologic cancer	2.5e-05	0.000123	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—hematologic cancer	2.43e-05	0.000119	CcSEcCtD
Trifluoperazine—Nausea—Prednisone—hematologic cancer	2.41e-05	0.000118	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—hematologic cancer	2.4e-05	0.000118	CcSEcCtD
Trifluoperazine—Hypersensitivity—Epirubicin—hematologic cancer	2.34e-05	0.000115	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—hematologic cancer	2.33e-05	0.000115	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—hematologic cancer	2.32e-05	0.000114	CcSEcCtD
Trifluoperazine—Asthenia—Epirubicin—hematologic cancer	2.27e-05	0.000112	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—hematologic cancer	2.24e-05	0.00011	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—hematologic cancer	2.24e-05	0.00011	CcSEcCtD
Trifluoperazine—Hypersensitivity—Doxorubicin—hematologic cancer	2.16e-05	0.000106	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—hematologic cancer	2.14e-05	0.000105	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—hematologic cancer	2.13e-05	0.000105	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—hematologic cancer	2.12e-05	0.000104	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—hematologic cancer	2.1e-05	0.000103	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—hematologic cancer	2.1e-05	0.000103	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—hematologic cancer	2.07e-05	0.000102	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—hematologic cancer	2.01e-05	9.89e-05	CcSEcCtD
Trifluoperazine—Rash—Epirubicin—hematologic cancer	2e-05	9.83e-05	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—hematologic cancer	2e-05	9.82e-05	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—hematologic cancer	1.99e-05	9.76e-05	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—hematologic cancer	1.94e-05	9.54e-05	CcSEcCtD
Trifluoperazine—Nausea—Epirubicin—hematologic cancer	1.88e-05	9.26e-05	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—hematologic cancer	1.85e-05	9.09e-05	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—hematologic cancer	1.85e-05	9.08e-05	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—hematologic cancer	1.84e-05	9.03e-05	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—hematologic cancer	1.74e-05	8.57e-05	CcSEcCtD
Trifluoperazine—CALM3—Disease—TGFB1—hematologic cancer	1.24e-06	8.04e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.24e-06	8.03e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.24e-06	8.03e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MAPK3—hematologic cancer	1.23e-06	8.01e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MAPK3—hematologic cancer	1.23e-06	8.01e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.23e-06	8.01e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JAK2—hematologic cancer	1.23e-06	8e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JAK2—hematologic cancer	1.23e-06	8e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.23e-06	8e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—hematologic cancer	1.23e-06	7.99e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.23e-06	7.98e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.23e-06	7.98e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.23e-06	7.96e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—hematologic cancer	1.22e-06	7.93e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.21e-06	7.87e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	1.21e-06	7.86e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MTOR—hematologic cancer	1.21e-06	7.86e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.21e-06	7.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTEN—hematologic cancer	1.21e-06	7.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTEN—hematologic cancer	1.21e-06	7.85e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.21e-06	7.85e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.21e-06	7.84e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.21e-06	7.84e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.21e-06	7.83e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.21e-06	7.83e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—hematologic cancer	1.21e-06	7.83e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.2e-06	7.81e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—hematologic cancer	1.2e-06	7.81e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—hematologic cancer	1.2e-06	7.81e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	1.2e-06	7.81e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—hematologic cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—hematologic cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—hematologic cancer	1.2e-06	7.79e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—hematologic cancer	1.2e-06	7.79e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.2e-06	7.78e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.2e-06	7.78e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—hematologic cancer	1.2e-06	7.77e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—hematologic cancer	1.2e-06	7.77e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—hematologic cancer	1.19e-06	7.74e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.19e-06	7.71e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.19e-06	7.71e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.18e-06	7.66e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.18e-06	7.64e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.17e-06	7.58e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.17e-06	7.57e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.16e-06	7.51e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.15e-06	7.5e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—hematologic cancer	1.15e-06	7.49e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—hematologic cancer	1.15e-06	7.49e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.15e-06	7.45e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—hematologic cancer	1.15e-06	7.44e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.14e-06	7.43e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.14e-06	7.43e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.14e-06	7.42e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.14e-06	7.42e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—hematologic cancer	1.14e-06	7.41e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.14e-06	7.39e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.14e-06	7.37e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.13e-06	7.37e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—hematologic cancer	1.13e-06	7.37e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.13e-06	7.31e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.12e-06	7.3e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.12e-06	7.3e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.12e-06	7.28e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.12e-06	7.27e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.12e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.12e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.12e-06	7.25e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.11e-06	7.23e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.11e-06	7.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.11e-06	7.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—hematologic cancer	1.11e-06	7.22e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—hematologic cancer	1.11e-06	7.2e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—hematologic cancer	1.11e-06	7.2e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.11e-06	7.18e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—hematologic cancer	1.11e-06	7.18e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—hematologic cancer	1.1e-06	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—hematologic cancer	1.1e-06	7.17e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.1e-06	7.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	1.1e-06	7.13e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	1.1e-06	7.13e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.1e-06	7.12e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.09e-06	7.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—hematologic cancer	1.08e-06	7.03e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—hematologic cancer	1.08e-06	7.02e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—hematologic cancer	1.08e-06	6.99e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—hematologic cancer	1.08e-06	6.99e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.08e-06	6.99e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—hematologic cancer	1.07e-06	6.98e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—hematologic cancer	1.07e-06	6.98e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.07e-06	6.97e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—hematologic cancer	1.07e-06	6.95e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—hematologic cancer	1.07e-06	6.95e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—hematologic cancer	1.06e-06	6.91e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.06e-06	6.89e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.06e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.06e-06	6.86e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—hematologic cancer	1.06e-06	6.85e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.05e-06	6.84e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—hematologic cancer	1.05e-06	6.84e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	1.05e-06	6.8e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—hematologic cancer	1.05e-06	6.8e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—hematologic cancer	1.05e-06	6.8e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.05e-06	6.8e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—hematologic cancer	1.05e-06	6.79e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—hematologic cancer	1.05e-06	6.79e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTEN—hematologic cancer	1.05e-06	6.79e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.04e-06	6.78e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.04e-06	6.78e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.04e-06	6.77e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.03e-06	6.68e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.03e-06	6.67e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.02e-06	6.66e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.02e-06	6.66e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.02e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	1.02e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.02e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—hematologic cancer	1.02e-06	6.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—hematologic cancer	1.02e-06	6.63e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	1.02e-06	6.62e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—hematologic cancer	1.02e-06	6.62e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—hematologic cancer	1.02e-06	6.62e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-06	6.58e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-06	6.58e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTEN—hematologic cancer	1.01e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTEN—hematologic cancer	1.01e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—hematologic cancer	1.01e-06	6.56e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1e-06	6.52e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—hematologic cancer	9.97e-07	6.47e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—hematologic cancer	9.95e-07	6.46e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—hematologic cancer	9.91e-07	6.44e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—hematologic cancer	9.9e-07	6.43e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	9.89e-07	6.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	9.89e-07	6.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	9.86e-07	6.41e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	9.86e-07	6.41e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	9.83e-07	6.38e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—hematologic cancer	9.77e-07	6.35e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—hematologic cancer	9.77e-07	6.35e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—hematologic cancer	9.74e-07	6.33e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SRC—hematologic cancer	9.69e-07	6.3e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	9.67e-07	6.28e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	9.65e-07	6.27e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—hematologic cancer	9.64e-07	6.26e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—hematologic cancer	9.64e-07	6.26e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	9.51e-07	6.18e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	9.49e-07	6.17e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	9.48e-07	6.16e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTEN—hematologic cancer	9.47e-07	6.15e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	9.47e-07	6.15e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	9.46e-07	6.15e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	9.44e-07	6.13e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—hematologic cancer	9.42e-07	6.12e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—hematologic cancer	9.42e-07	6.12e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SRC—hematologic cancer	9.38e-07	6.09e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SRC—hematologic cancer	9.38e-07	6.09e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—hematologic cancer	9.35e-07	6.07e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NRAS—hematologic cancer	9.33e-07	6.06e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—hematologic cancer	9.32e-07	6.06e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—hematologic cancer	9.32e-07	6.05e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	9.13e-07	5.93e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	9.13e-07	5.93e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—hematologic cancer	9.11e-07	5.91e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—hematologic cancer	9.06e-07	5.88e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—hematologic cancer	9.04e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—hematologic cancer	9.04e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—hematologic cancer	9.03e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	9.03e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NRAS—hematologic cancer	9.02e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NRAS—hematologic cancer	9.02e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—hematologic cancer	9.02e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—hematologic cancer	9.02e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—hematologic cancer	9.01e-07	5.85e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—hematologic cancer	9.01e-07	5.85e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	8.93e-07	5.8e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	8.88e-07	5.77e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	8.86e-07	5.76e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—hematologic cancer	8.82e-07	5.73e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	8.75e-07	5.68e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—hematologic cancer	8.73e-07	5.67e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	8.72e-07	5.67e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	8.7e-07	5.65e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—hematologic cancer	8.69e-07	5.64e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	8.67e-07	5.63e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	8.64e-07	5.61e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	8.64e-07	5.61e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—hematologic cancer	8.6e-07	5.59e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	8.59e-07	5.58e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—hematologic cancer	8.58e-07	5.57e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—hematologic cancer	8.53e-07	5.54e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—hematologic cancer	8.53e-07	5.54e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—hematologic cancer	8.44e-07	5.48e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	8.41e-07	5.47e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—hematologic cancer	8.4e-07	5.46e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—hematologic cancer	8.4e-07	5.46e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	8.4e-07	5.46e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	8.38e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	8.38e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	8.36e-07	5.43e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	8.35e-07	5.43e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—hematologic cancer	8.32e-07	5.4e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—hematologic cancer	8.32e-07	5.4e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	8.22e-07	5.34e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	8.2e-07	5.33e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	8.07e-07	5.24e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	8.05e-07	5.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—hematologic cancer	8.03e-07	5.21e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—hematologic cancer	7.99e-07	5.19e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	7.87e-07	5.11e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—hematologic cancer	7.85e-07	5.1e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—hematologic cancer	7.76e-07	5.04e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—hematologic cancer	7.76e-07	5.04e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—hematologic cancer	7.72e-07	5.02e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	7.7e-07	5e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTEN—hematologic cancer	7.56e-07	4.91e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	7.38e-07	4.79e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	7.37e-07	4.79e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	7.26e-07	4.71e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	7.24e-07	4.7e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—hematologic cancer	7.21e-07	4.68e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—hematologic cancer	7.2e-07	4.68e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—hematologic cancer	7.13e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	7.13e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	7.13e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	7.13e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	7.11e-07	4.62e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—hematologic cancer	6.97e-07	4.53e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—hematologic cancer	6.97e-07	4.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—hematologic cancer	6.9e-07	4.48e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—hematologic cancer	6.9e-07	4.48e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—hematologic cancer	6.82e-07	4.43e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—hematologic cancer	6.68e-07	4.34e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—hematologic cancer	6.6e-07	4.29e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—hematologic cancer	6.6e-07	4.29e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—hematologic cancer	6.53e-07	4.24e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—hematologic cancer	6.32e-07	4.1e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—hematologic cancer	6.32e-07	4.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—hematologic cancer	6.02e-07	3.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—hematologic cancer	5.83e-07	3.78e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—hematologic cancer	5.83e-07	3.78e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—hematologic cancer	5.46e-07	3.55e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.34e-07	3.47e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—hematologic cancer	4.36e-07	2.83e-06	CbGpPWpGaD
